Elsevier Science, Inc.

SHERPA: Unknown

People

  1. D'Angelica
    D'Angelica
  2. Abou-Alfa
    Abou-Alfa
  3. Jarnagin
    Jarnagin
  4. Kingham
    Kingham
  5. Gonen
    Gonen
  6. Ilson
    Ilson
  7. Saltz
    Saltz
  8. Solomon
    Solomon
  9. Yarmohammadi
    Yarmohammadi
  10. Janjigian
    Janjigian

Groups

  1. Department of Medicine (141)
  2. Gastrointestinal Oncology Service (141)
  3. Solid Tumor Oncology Division (141)
  4. Center for Pancreatic Cancer Research (70)
  5. Surgery (51)
  6. Sloan Kettering Institute Postdocs (30)
  7. Survivorship Research (30)
  8. Epidemiology and Biostatistics (28)
  9. Radiology, Department of (28)
  10. Biostatistics Service (27)
Search Within
  1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (102)
  2. Meeting Abstract (24)
  3. Editorial (6)
  4. Correspondence (5)
  5. Review (3)
  6. Guidelines (1)
Groups
  1. Department of Medicine (141)
  2. Gastrointestinal Oncology Service (141)
  3. Solid Tumor Oncology Division (141)
  4. Center for Pancreatic Cancer Research (70)
  5. Surgery (51)
  6. Sloan Kettering Institute Postdocs (30)

More Groups

People
  1. Nancy Kemeny (29)
  2. Michael D'Angelica (25)
  3. Ghassan Abou-Alfa (22)
  4. William Jarnagin (22)
  5. T Peter Kingham (18)
  6. David Ilson (17)

More People

Years
  1. 2025 (4)
  2. 2024 (5)
  3. 2023 (13)
  4. 2022 (12)
  5. 2021 (18)
  6. 2020 (11)

More Years

Publications
  1. Lancet Oncology (42)
  2. Journal of Vascular and Interventional Radiology (24)
  3. Journal of the American College of Surgeons (21)
  4. HPB (14)
  5. Lancet (8)
  6. Journal of Hepatology (7)

More Publications

Results (141)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Reply to: “STRIDE's efficacy and safety in Asian hepatocellular carcinoma”
    Correspondence

    Lau, G.; Abou-Alfa, G. K.; Chan, S. L.
    Journal of Hepatology (2025)

    Fulltext@MSK | Save
  • Landscape of subsequent therapies in perioperative immunotherapy trials across multiple cancer types
    Journal Article

    Semaan, K.; Nawfal, R.; Nally, E.; Janjigian, Y. Y.; Robert, C.; Peters, S.; Powles, T.; Choueiri, T. K.
    Lancet Oncology (2025)

    Fulltext@MSK | Save
  • Outcomes in the Asian subgroup of the phase III randomised HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
    Journal Article

    Lau, G.; Abou-Alfa, G. K.; Cheng, A. L.; Sukeepaisarnjaroen, W.; Van Dao, T.; Kang, Y. K.; Thungappa, S. C.; Kudo, M.; Sangro, B.; Kelley, R. K.; more...
    Journal of Hepatology (2025)

    Fulltext@MSK | Save
  • Non-inferiority trials: Tyranny or good governance? – Authors' reply
    Correspondence

    Tannock, I. F.; Buyse, M.; De Backer, M.; Earl, H.; Goldstein, D. A.; Ratain, M. J.; Saltz, L. B.; Sonke, G. S.; Strohbehn, G. W.
    Lancet Oncology (2025)

    Fulltext@MSK | Save
  • Early-onset colorectal cancer patients do not require shorter intervals for post-surgical surveillance colonoscopy
    Journal Article

    Mendelsohn, R. B.; Hahn, A. I.; Palmaira, R. L.; Saxena, A. R.; Mukthinuthalapati, P. K.; Schattner, M. A.; Markowitz, A. J.; Ludwig, E.; Shah, P.; Calo, D.; more...
    Clinical Gastroenterology and Hepatology (2024)

    Fulltext@MSK | Save
  • The tyranny of non-inferiority trials
    Editorial

    Tannock, I. F.; Buyse, M.; De Backer, M.; Earl, H.; Goldstein, D. A.; Ratain, M. J.; Saltz, L. B.; Sonke, G. S.; Strohbehn, G. W.
    Lancet Oncology (2024)

    Fulltext@MSK | Save
  • Receptor tyrosine kinase inhibition results in the regression of acral melanoma by targeting the tumor microenvironment
    Meeting Abstract

    Smith, E. A.; Belote, R. L.; Cruz, N. E.; Mustafa, T. E.; Becker, C.; Alizada, S.; Chan, T.; Seasor, T. A.; Balatico, M.; Cortes-Sanchez, E.; more...
    Journal of Investigative Dermatology (2024)

    Fulltext@MSK | Save
  • Immunotherapy for resectable locally advanced esophageal carcinoma
    Journal Article

    Fick, C. N.; Dunne, E. G.; Sihag, S.; Molena, D.; Cytryn, S. L.; Janjigian, Y. Y.; Wu, A. J.; Worrell, S. G.; Hofstetter, W. L.; Jones, D. R.; more...
    Annals of Thoracic Surgery (2024)

    Fulltext@MSK | Save
  • Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): An interim analysis of the multicentre, double-blind, randomised phase 3 study
    Journal Article

    Shitara, K.; Rha, S. Y.; Wyrwicz, L. S.; Oshima, T.; Karaseva, N.; Osipov, M.; Yasui, H.; Yabusaki, H.; Afanasyev, S.; Park, Y. K.; more...
    Lancet Oncology (2024)

    Fulltext@MSK | Save
  • Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: Interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial
    Journal Article

    Janjigian, Y. Y.; Kawazoe, A.; Bai, Y.; Xu, J.; Lonardi, S.; Metges, J. P.; Yanez, P.; Wyrwicz, L. S.; Shen, L.; Ostapenko, Y.; more...
    Lancet (2023)

    Fulltext@MSK | Save